https://pure.eur.nl/en/publications/alemtuzumab-as-antirejection-therapy-t-cell-repopulation-and-cyto/
Alemtuzumab as Antirejection Therapy: T Cell Repopulation and Cytokine Responsiveness - Erasmus...
t cellalemtuzumabtherapy
https://www.uclahealth.org/news/publication/pioneering-protocol-could-enable-transplant-recipients
Pioneering protocol could enable transplant recipients to thrive without antirejection drugs | UCLA...
Performing human-organ transplants without the necessity for a lifetime regimen of immunosuppressive drugs has been an enduring goal for transplantation...
transplant recipients